News

TU Dresden researchers have identified proteins that could be targeted to develop new immunotherapies against colon cancer. Their results also underline the central role of intestinal bacteria in the development of the disease.

A new study has found that women’s health research remains disproportionately focused on the reproductive years - particularly on pregnancy – with few articles on the major causes of illness and death in women.

In The BMJ, Mohga Kamal-Yanni, a consultant in global health policy and access to medicines, argues that the pandemic offers a chance for governments to retain control by sharing knowledge and waiving intellectual property rules.

A new platform has been designed to deliver a universal influenza vaccine candidate to immune cells and the results in mice are suggesting that the immunization effectively protects against multiple flu strains.

University of Liverpool scientists have taken a significant step towards unlocking the medical potential of a new class of potent antibiotic capable of killing "superbugs" including MRSA without detectable resistance.

Scientists have shown that responses to the Pfizer-BioNTech BNT162b2 mRNA vaccine differ significantly in individuals based on whether or not they were previously infected with SARS-CoV-2.

In a pre-clinical study published in Nature Biomedical Engineering, a team at the University of Pennsylvania abbreviated the manufacture of CAR T cells and generated functional cells with enhanced anti-tumor potency in just 24 hours.

New research suggests that the drug sargramostim, currently being trialed in Alzheimer’s patients, may also improve cognitive function in people with Down syndrome.

A survey has been conducted to uncover how the public feels about the distribution of vaccines.

Biochemists have studied how composition affects passive diffusion and the robustness of the cell membrane.